Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million?
Key Points
Palisades Investment Partners initiated a 369,476-share position in Amprius Technologies; estimated trade value $4.82 million (based on the quarterly average price).
The quarter-end Amprius Technologies stake value rose by $6.23 million, reflecting both purchase and price appreciation.
The position represents a 1.89% change in fund’s 13F reportable assets under management.
Amprius Technologies now accounts for 2.44% of 13F AUM, placing it outside the fund’s top five holdings.
What happened
Palisades Investment Partners, LLC initiated a new stake in Amprius Technologies (NYSE:AMPX), acquiring 369,476 shares in the first quarter of 2026. The estimated transaction value was $4.82 million, calculated using the period’s average closing price. As of March 31, 2026, the Amprius Technologies position was valued at $6.23 million. Full details are available in the SEC filing dated April 30, 2026.
What else to know
- This was a new position for Palisades Investment Partners, LLC, now making up 2.44% of its 13F reportable assets under management.
- Top five holdings after the filing:
- NYSE:SPXC: $24.68 million (9.7% of AUM)
- NASDAQ:KRYS: $11.73 million (4.6% of AUM)
- NYSE:PKE: $11.42 million (4.5% of AUM)
- NYSE:PAY: $10.90 million (4.3% of AUM)
- NYSEMKT:IWM: $8.45 million (3.3% of AUM)
- As of April 29, 2026, Amprius Technologies shares were priced at $20.34, up 816.2% over the past year, outpacing the S&P 500 by 787.89 percentage points.
- Amprius Technologies reported trailing twelve-month revenue of $73.01 million and a net loss of $44.02 million for the period ending December 31, 2025.
Company overview
| Metric | Value |
|---|---|
| Price (as of market close April 29, 2026) | $20.34 |
| Market capitalization | $2.89 billion |
| Revenue (TTM) | $73.01 million |
| Net income (TTM) | ($44.02 million) |
Company snapshot
- Amprius Technologies manufactures and distributes silicon nanowire anode lithium-ion batteries, serving aerospace, defense, and electric vehicle markets.
- It generates revenue through the sale of lithium-ion battery products.
- The company targets OEMs and enterprises in the aerospace, defense, and electric mobility sectors seeking high-performance energy storage solutions.
Amprius Technologies manufactures and distributes lithium-ion batteries, including products using silicon nanowire anode technology. It serves the aerospace, defense, and electric vehicle industries.
What this transaction means for investors
Los Angeles-based Palisades Investment Partners’ Q1 purchase of Amprius Technologies shares is a noteworthy event for investors, since the buy was a new stake, suggesting the investment advisory firm has a bullish outlook towards the stock.
The investment was a good move, with Amprius Technologies shares hitting a 52-week high of $22.80 in April. The stock is surging thanks to strong business performance.
Amprius exited 2025 with sales of $73.01 million, which represents jaw-dropping 202% growth over 2024. But the good news doesn’t stop there. The company expects 2026 revenue to reach at least $125 million. It announced a massive $21 million purchase order in March from a Chinese company, indicating its business in China, one of the world’s largest electric vehicle markets, is robust.
Amprius Technologies looks like a solid investment, so it’s no surprise Palisades Investment Partners decided to jump in. But with shares soaring, Amprius’ price-to-sales ratio of 35 is more than double what it was a year ago, suggesting the stock is expensive. Now looks like a good time to sell, but wait for the price to drop before deciding to buy.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Krystal Biotech. The Motley Fool has a disclosure policy.